Advancing Therapy in Basal Insulin-Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

被引：0
|
作者：
Home, Philip
McCrimmon, Rory J.
Rosenstock, Julio
Bluher, Matthias
Pegelow, Katrin
Melas-Melt, Lydie
Djaballah, Khier
Giorgino, Francesco
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-845-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
845-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Advancing Therapy in Basal Insulin-Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function
    Home, Philip
    Rosenstock, Julio
    Giorgino, Francesco
    Bluher, Matthias
    Djaballah, Khier
    Pegelow, Katrin
    Melas-Melt, Lydie
    [J]. DIABETES, 2022, 71
  • [2] Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial
    Mccrimmon, Rory J.
    Home, Philip
    Cheng, Alice Y.
    Giorgino, Francesco
    Fonseca, Vivian
    Souhami, Elisabeth
    Alvarez, Agustina
    Boss, Anders H.
    Melas-Melt, Lydie
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [3] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial
    Mccrimmon, Rory J.
    Cheng, Alice Y.
    Fonseca, Vivian
    Choza, Ricardo
    Alessa, Thamer
    Alvarez, Agustina
    Souhami, Elisabeth
    Boss, Anders H.
    Picard, Pascaline
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [4] Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial
    McCrimmon, Rory J.
    Al Sifri, Saud
    Emral, Rifat
    Mohan, Viswanathan
    Sauque-Reyna, Leobardo
    Trescoli, Carlos
    Lalic, Nebojsa
    Alvarez, Agustina
    Demil, Nacima
    Coudert, Mathieu
    Shaunik, Alka
    Bonnemaire, Mireille
    Rosenstock, Julio
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (06): : 1221 - 1231
  • [5] Advancing therapy in people with suboptimally controlled basal insulin-treated type 2 diabetes: Subanalysis of the SoliMix trial in participants in Latin American countries
    Frechtel, Gustavo
    Sauque-Reyna, Leobardo
    Choza-Romero, Ricardo
    Anguiano, Luis
    Melas-Melt, Lydie
    Sanudo-Maury, Maria Elena
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2526 - 2534
  • [6] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    [J]. DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [7] Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin-Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial
    Giorgino, Francesco
    Rosenstock, Julio
    Ritzel, Robert
    Deyneli, Oguzhan
    Alvarez, Agustina
    Souhami, Elisabeth
    Melas-Melt, Lydie
    McCrimmon, Rory J.
    [J]. DIABETES, 2022, 71
  • [8] Impact of hypoglycaemia on insulin titration and fasting plasma glucose in basal insulin-treated type 2 diabetes: a subanalysis of the SoliMix trial
    Ritzel, R.
    McCrimmon, R. J.
    Rosenstock, J.
    Deyneli, O.
    Alvarez, A.
    Souhami, E.
    Melas-Melt, L.
    Giorgino, F.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S328 - S328
  • [9] Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial
    Rosenstock, Julio
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Trescoli, Carlos
    Al Sifri, Saud
    Lalic, Nebojsa
    Alvarez, Agustina
    Picard, Pascaline
    Bonnemaire, Mireille
    Demil, Nacima
    McCrimmon, Rory J.
    [J]. DIABETES CARE, 2021, 44 (10) : 2361 - 2370
  • [10] Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial (vol 23, pg 1221, 2021)
    McCrimmon, R. J.
    Al Sifri, S.
    Emral, R.
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (11): : 2600 - 2600
12345